Abstract:Abstract Introduction: Current variant classification (VC) frameworks rely on rules-based approaches that use heuristic weighting of various types of evidence, resulting in > 50% of variants being classified as variants of uncertain significance (VUS), and leaving many patients with uncertainty about their disease risk or diagnosis. We propose a probabilistic and scalable Bayesian approach to model the causal relationships between various types of evidence. A fully quantitative system maximizes the utility and integration of various evidence types, empowering clinicians to make more nuanced management decisions. Methods: Probabilistic graphical models (PGMs) are uniquely suited to the needs of clinical VC. Two different component PGMs were developed to model two of the evidence categories that will ultimately be used in a comprehensive VC system: population allele frequency (Population PGM) and reported phenotype observations (Reported Phenotype PGM). Results: The Population PGM treats population allele frequency observations as a binomial process. By conditioning the model on partial observations, the probabilistic relationships between pathogenicity and allele frequencies can be estimated while stochastic variational inference allows uncertainty to be efficiently propagated. The resulting model performs well across a large number of genes at inferring pathogenicity of a variant from its allele frequency, with an average precision of >99% for benign variants. In the Reported Phenotype PGM, phenotypic features characteristic of a disorder are learned from patients expected to be affected based on genotype. Patient-level predictions are in turn combined at the variant level to derive variant pathogenicity likelihoods. To date, models representing at least 102 inherited conditions and 259 genes have demonstrated high predictive performance (>0.8 AUROC) for both patient-level and variant-level predictions. Finally, as a proof-of-concept, we demonstrate how each component PGM can be combined into a probabilistic Bayesian VC framework that also includes protein structure and stability, evolutionary conservation, and sequence context. This framework has high concordance with known, well-accepted pathogenic and benign variants classified with rules-based systems, and could make high-confidence predictions for many variants currently classified as VUS. Conclusion: We present a Bayesian approach that can integrate diverse types of evidence to achieve high VC accuracy while quantifying uncertainty. Future expansion of this Bayesian framework to all evidence types relevant to VC may allow for more accurate risk management guidelines and further inform medical and genetic counseling recommendations. Citation Format: Wolfgang Michael Korn, Yuya Kobayashi, Flavia M. Facio, Arun Nampally, Keith Nykamp, Robert Nussbaum, Alexandre Colavin, Britt Johnson, Toby Manders. Continuous, probabilistic variant interpretation with Bayesian graphical models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 792.

Variational Bayes latent class approach for EHR-based phenotyping with large real-world data

Assessing an Alternative for `Negative Variance Components': A Gentle Introduction to Bayesian Covariance Structure Modelling for Negative Associations Among Patients with Personalized Treatments

A Bayesian Approach to Modelling Longitudinal Data in Electronic Health Records

Bayesian Profiling Multiple Imputation for Missing Electronic Health Records

Fast and accurate Bayesian polygenic risk modeling with variational inference

Large language models facilitate the generation of electronic health record phenotyping algorithms

A Bayesian latent class model for predicting gestational age in health administrative data

Divide-and-Conquer MCMC for Multivariate Binary Data

A Semiparametric Approach for Robust and Efficient Learning with Biobank Data

Bayesian Inference of Individualized Treatment Effects using Multi-task Gaussian Processes

Abstract 792: Continuous, probabilistic variant interpretation with Bayesian graphical models

A Bayesian latent class extension of naive Bayesian classifier and its application to the classification of gastric cancer patients

Large Language Models with Retrieval-Augmented Generation for Zero-Shot Disease Phenotyping

Exploring Long-Term Prediction of Type 2 Diabetes Microvascular Complications

A Large Language Model Outperforms Other Computational Approaches to the High-Throughput Phenotyping of Physician Notes

Bayesian hierarchical vector autoregressive models for patient-level predictive modeling

A multivariate hierarchical Bayesian framework for healthcare predictions with application to medical home study in the Department of Veteran Affairs

High Performance Implementation of the Hierarchical Likelihood for Generalized Linear Mixed Models. An Application to estimate the potassium reference range in massive Electronic Health Records datasets

Language-model-based patient embedding using electronic health records facilitates phenotyping, disease forecasting, and progression analysis

Latent-state models for precision medicine